In Listeria monocytogenes, a gram-positive, facultative intracellular pathogen causing systemic infections in humans and animals (25, 51) , most of the known virulence genes involved in internalization and intracellular replication are under the control of the central transcription factor PrfA (3, 5, 29, 32) . This listerial virulence regulator belongs to the large Crp/Fnr family of transcriptional activators (28) . Like most other members of this family, it acts as a dimer and binds to a specific 14-bp-long sequence of dyad symmetry (the PrfA box) (12, 13, 33, 48) . In a typical functional PrfA-dependent promoter, the PrfA box (which may possess mismatches in one or two positions in comparison to the consensus sequence) is located 22 or 23 bp apart from a sigma A (SigA)-specific Ϫ10 box. A typical Ϫ35 box is normally not found, and its presence may even inhibit the activation by PrfA. Certain sequences within the interspace region (between the Ϫ10 and the PrfA boxes) or adjacent to these sequences may positively or negatively influence the functionality of a PrfA-dependent promoter (15, 30, 31) .
The expression of the prfA gene is controlled by three promoters. P1, which is under the control of SigA and thermoregulated (11, 12, 20) , and P2, which is SigB regulated (37, 40, 46) , are located in front of prfA, while the third one, in front of the adjacent plcA gene, initiates transcription of prfA into a bicistronic mRNA. The latter promoter is controlled by PrfA, thus causing autoregulation of prfA transcription (32) . In addition to this complex transcriptional control of prfA, translation of the monocistronic prfA mRNA is thermoregulated by the formation of a secondary structure in the untranslated 5Ј region of this transcript which acts as a thermoswitch (20) .
Furthermore, the activity of PrfA is modulated by yet unknown factors that seem to be produced under certain environmental and nutritional conditions (7, 10, 34, 35, 41, 43) . The crystal structure of PrfA suggests a potential binding domain for putative effector molecules which may stabilize the helixturn-helix domain and, thus, could enhance the binding affinity of PrfA to its DNA target site (9) . The identification of several mutations in prfA leading to PrfA proteins (PrfA*) which are constitutively active and no longer modulated in their activity by external conditions (36, 42, 49, (52) (53) (54) are in line with this assumption.
In analogy to the structurally similarity of the cAMP-binding Crp of Escherichia coli to PrfA, it has been postulated that PrfA might also be activated by similar hypothetical factor(s) (1, 2, 7, 42) . Purified PrfA protein seems to be functional and initiates transcription at PrfA-dependent promoters in an in vitro transcription system in the absence of an additional factor(s) (1, 27, 31) . However, the requirement of additional activators or repressors of PrfA in vivo cannot be ruled out. The activity of purified PrfA* in these in vitro transcription assays was still higher than that of wild-type PrfA (31, 53) , but this increased activity may simply be caused by the structural differences in the helix-turn-helix domain of the two PrfA proteins (9, 42) . The PrfA proteins used in these in vitro transcription assays carried His 6 or Flag tags at the N termini, and it has been argued that these tags may cause higher binding affinity and, hence, better transcriptional activation than the untagged wild-type PrfA. Nevertheless, these findings seem to favor the idea that modulation of PrfA activity is brought about by negatively acting effector molecules whose removal may lead to full activity of PrfA more than that it is brought about by molecules activating an initially inactive PrfA. More recent data also seem to favor this assumption (10, 19 ; S. Mertins, unpublished data).
The occurrence of the prfA gene is not restricted to virulent L. monocytogenes isolates, as its presence together with an entire prfA gene cluster has been also demonstrated in Listeria ivanovii, an animal pathogen, and Listeria seeligeri, an apathogenic Listeria species (4, 16, 24, 45) . Evidence based on previous studies suggests that the activities of PrfA of L. ivanovii and L. seeligeri may be different from that of L. monocytogenes (4, 14, 23) .
To obtain a deeper insight into the properties of these PrfA proteins, we purified the proteins of these Listeria species and determined their binding affinity to their specific target sequences (PrfA boxes) and their capacities to promote transcription initiation at various PrfA-dependent promoters of L. monocytogenes, L. ivanovii, and L. seeligeri. We also compared binding and transcriptional activation capacities of purified untagged and His 6 -tagged PrfA and PrfA* proteins of L. monocytogenes. The results reveal significant differences between these PrfA proteins which could shed light on the evolution of pathogenic Listeria bacteria.
MATERIALS AND METHODS
General techniques. PCR amplifications, cloning procedures, isolation of chromosomal DNA, and DNA manipulations were carried out according to standard procedures (44) . Cycle sequencing was performed using the CEQ Dye Terminator Cycle Sequencing Quick Start kit (Beckman Coulter), and sequencing reactions were run on an XL2000 Beckman Coulter sequencer. The Listeria homepage of the Institut Pasteur (http://genolist.pasteur.fr/ListiList/) and the NCBI database (http://www.ncbi.nlm.nih.gov/) were used for sequence comparison. All oligonucleotides used for PCR amplification were synthesized by SigmaGenosys and are listed in Table 1 . Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie blue staining were performed according to standard protocols (26) .
Purification of RNAP. The purification of RNA polymerase (RNAP) was achieved via heparin-Sepharose affinity chromatography as previously described (1) , with the following modification: the strain used was the mutant L. monocytogenes EGD-e ⌬prfA ⌬sigB (50) , which additionally lacked the sigB gene. The purity of RNAP (␣, ␤, and ␤Ј subunits plus SigA) was about 30 to 40%, as determined by silver-stained SDS-PAGE.
Purification of untagged PrfA proteins of L. monocytogenes EGD-e and L. monocytogenes P14-A. PCR fragments carrying the prfA and prfA* genes were amplified using the primers m-prfA-Nde and m-prfA-Bgl (Table 1) and chromosomal DNA of L. monocytogenes EGD-e wild type or L. monocytogenes P14-A (42) as the template. The purified fragments were digested with NdeI and BglII and subsequently cloned into the pET-3c expression vector (Novagen), yielding the plasmids pET-3c-PrfA nt and pET-3c-PrfA* nt . The nucleotide sequences of the amplified sequences were verified by automated sequencing. The pET-3c vectors were transformed into E. coli FT1(pLysS), and expression of the native PrfA proteins was performed as described by the manufacturer (pET system; Novagen). Bacteria were lysed in sample buffer (50 mM sodium phosphate [pH 7.0], 50 mM NaCl, 10% glycerol, Complete protease inhibitor [Roche]) by using a Fast Prep FP120 shaker (Thermo Savant). Cell debris was pelleted by centrifugation for 1 h at 10,000 rpm and 4°C; subsequently, the supernatants containing soluble proteins were filtered.
Purification of nontagged PrfA Lm and nontagged PrfA* Lm was achieved by cation exchange chromatography on a 1-ml HiTrap SP Fast Flow Sepharose column (Amersham Biosciences) applied to an Ä KTAprime protein purification system (Amersham Biosciences). After a washing step (50 mM sodium phosphate [pH 7.0], 50 mM NaCl, and 10% [vol/vol] glycerol), the proteins were eluted with an NaCl gradient up to 500 mM. Fractions containing the nontagged PrfA Lm and PrfA* Lm proteins were determined by the use of Coomassie brilliant blue-stained SDS-PAGE gels. Proteins were finally stored in 50 mM sodium phosphate (pH 7.0), 500 mM NaCl, and 10% (vol/vol) glycerol at Ϫ80°C.
Purification of His 6 -tagged PrfA proteins of L. monocytogenes, L. ivanovii, L. seeligeri, and hybrid PrfA Lsm . PrfA Lm and PrfA* Lm were purified as described previously (2) . PCR fragments carrying the prfA genes prfA Li and prfA Ls were amplified using the primers listed in Table 1 , and chromosomal DNA of L. ivanovii (ATCC 19119) or L. seeligeri (SLCC 3954) was used as the template. The resulting fragments were cloned into the vector pQE30 (QIAGEN), generating the vectors pQE30-i-prfA and pQE30-s-prfA. To forge the hybrid PrfA Lsm , two PCR fragments were generated, the first using the primers s-prfA-Bam, s-prfArkmb2, and pQE30-s-prfA as the template and the second using m-prfA-rkmb, m-prfA-Pst, and chromosomal DNA of L. monocytogenes EGD-e as the template. The fragments were fused by recombinant PCR and reamplified with the primer pair s-prfA-Bam and m-prfA-Pst. The product was cloned into pQE30, generating the vector pQE30-sm-prfA.
The pQE vectors were transformed into E. coli M15, and protein purification was carried out following the manufacturer's instructions (QIAGEN Expressionist). Proteins were finally stored in 50 mM Tris (pH 8.0), 150 mM NaCl, 1 mM EDTA, 2.5 mM CaCl 2 , 1 mM dithiothreitol (DTT), and 20% (vol/vol) glycerol at Ϫ80°C.
Preparation of Phly Lm PrfA box DNA for surface plasmon resonance (SPR) measurements. Twenty-eight-nucleotide synthetic oligonucleotides (Table 1) containing the Phly Lm PrfA box (forward, SPR-hly1; backward, SPR-hly2) or a nonspecific DNA sequence (forward, SPR-ctrl1; backward, SPR-ctrl2) were hybridized and used for analyses without further purification. Both forward 28-nucleotide oligonucleotides are biotinylated at the 5Ј end. All oligonucleotides were purchased with or without modification from MWG Biotech (Ebersberg, Germany).
Surface plasmon resonance measurements. SPR measurements were performed using a Biacore X instrument operated at 25°C. For the kinetic analyses, 100 response units of the biotinylated DNA fragment with the Phly Lm PrfA box were immobilized on a streptavidin-coated SA sensorchip (Biacore AB, Uppsala, Sweden) in flow cell two at a flow rate of 5 l/min. Flow cell one contained the biotinylated nonspecific DNA fragment as a reference. During immobilization and interaction analyses, HBS-EP buffer (0.01 M HEPES, pH 7.4, 0.15 M NaCl, 3 mM EDTA, 0.005% polysorbate) purchased from Biacore AB (Uppsala, Sweden) was used as a running buffer. The mass transport limitation was tested by the alteration of flow rates. A flow rate of 40 l/min was suitable to minimize mass transport, except for the case with PrfA* Lm , for all experiments. Concentrations of 0.5 to 100 nM of the PrfA proteins were used for titrations of the Phly Lm PrfA box. To regenerate the chip surface, the dissociation of the PrfA protein complex was stopped by an injection of 10 l 1 M NaCl buffer at 20 l/min after each injection. We fitted the resulting sensorgrams according to the 1:1 Langmuir binding model or to the 1:1 Langmuir binding model with mass transfer for PrfA* Lm by using the BIAevaluation 3.1 software. The fits showed chi-square values between 1 and 10. The titrations for the kinetic measurements were carried out twice for each PrfA protein, and the mean values and the deviations of all constants were calculated.
Electrophoretic mobility shift assay (EMSA). The double-stranded DNA probes were obtained by PCR amplification using the primers listed in Table 1 . After gel purification, the amounts of the PCR fragments were quantified (Ultrospec 2100 Pro photometer; Amersham). A total of 0. 8 .0], 5 mM DTT, 15% Ficoll), 1.5 l poly(dI-dC) (1 g/l), 1.5 l bovine serum albumin (1 g/l), and 3 l MgSO 4 (100 mM) in a final volume of 22.5 l. Reaction mixtures were preincubated for 3 min at 37°C following 22 min on ice. For CI complex formation, partially purified RNAP (1.5 nM) from L. monocytogenes or an RNAP-buffer mix were added to this mixture and further incubated for 5 min at 37°C. The DNA-protein complexes were separated on native 5% polyacrylamide gels in low-ionic-strength buffer (0.4ϫ Tris-borate-EDTA) at 250 V and 100 mA for 3.5 h at room temperature. Following electrophoresis, gels were vacuum dried and visualized by phosphorimaging (Molecular Dynamics Typhoon 9200; Amersham).
For supershift assays, anti-PrfA antiserum (with a final dilution of the antibodies of 1:15) was added after incubation with RNAP, and the binding reaction was continued for an additional 25 min on ice before the samples were loaded onto the gel.
In vitro transcription assay. For the in vitro transcription assay, the promoter region and the adjacent sequences of the actA and hly genes of L. monocytogenes EGD-e, L. ivanovii (ATCC 19119) and L. seeligeri (SLCC 3954) were amplified by PCR using the primer pairs listed in Table 1 . The purified DNA was cloned into the vector pUC18, which, after linearization, served as a template in runoff transcription assays, resulting in transcript sizes of about 135 bp.
Each reaction mix was prepared with 11 l of a master mix (86 mM Tris, 1.15 mM EDTA, 32. Bacterial strains and growth conditions. The E. coli strain DH5␣ was used for cloning and construction of the mutagenesis vectors. L. monocytogenes EGD-e strains were grown in brain heart infusion (Difco), in Luria-Bertani medium, or in chemically defined minimal medium (39) supplemented with carbohydrates for Listeria monocytogenes at 37°C. Erythromycin was used at concentrations of 5 g/ml for L. monocytogenes and 300 g/ml for E. coli.
Fresh stock solutions of carbohydrates (cellobiose and glycerol) were filter sterilized and added to the culture medium at a final concentration of 50 mM.
Allelic replacement of prfA Lm with prfA Ls in Listeria monocytogenes. In-frame allelic exchange of prfA genes was performed in parental strain L. monocytogenes EGD-e ⌬prfA (6) as described previously (21) . To construct EGD-e prfA Ls , three fragments of 306 bp, 704 bp, and 317 bp were amplified using the oligonucleotide pairs prfA_SalupϾ/ϽprfA_Alwup, s-prfA_bntϾ/Ͻs-prfA_Bse, and prfA_BsednϾ/ ϽprfA_Bamdn with chromosomal DNA of L. monocytogenes EGD-e and L. seeligeri (SLCC 3954) as templates. Fragments were then ligated via the introduced BsiHKAI and BseYI sites. After reamplification using the oligonucleotides prfA_SalupϾ and ϽprfA_Bamdn with the ligation mixture as a template, the resulting 1,288-bp fragment was cloned into pLSV101 (21) via SalI and BamHI sites, giving rise to pLSV101_s-prfA. This vector was transformed into L. monocytogenes EGD-e ⌬prfA by electroporation, and erythromycin-resistant bacteria growing at 42°C that harbored the chromosomally integrated plasmid were selected. After subsequent cultivation at 30°C, erythromycin-sensitive clones were screened by PCR to identify mutants for which the second recombination step resulted in an insertion of prfA Ls .
For a control, the original prfA gene of L. monocytogenes EGD-e (prfA Lm ) was inserted into the genome of L. monocytogenes EGD-e ⌬prfA to get a revertant with an identical genetic background. For this purpose, a 1,288-bp fragment was amplified using the oligonucleotide pairs prfA_SalupϾ and ϽprfA_Bgldn and chromosomal DNA of L. monocytogenes EGD-e as a template. The resulting fragment was cloned into pLSV101 via SalI and BglII/BamHI, giving rise to pLSV101_m-prfA. Subsequent procedures were performed as described above.
The allelic exchanges of the two mutants were confirmed by PCR analysis and sequencing.
Determination of hemolytic activity. Listeria monocytogenes strains were grown in minimal medium with 50 mM cellobiose or glycerol at 37°C to an optical density of 0.6 at 600 nm. The hemolytic activities in the supernatants were determined as described previously (43) .
Briefly, 20 l of culture supernatant was incubated in 1 ml of a 4% horse erythrocyte suspension for 30 min at 37°C. After incubation, the tubes were centrifuged at a relative centrifugal force (RCF) of 500 for 2 min at room temperature. The hemolytic activity was estimated by measuring absorption at 543 nm using an Ultrospec 2100 Pro photometer (Amersham).
Preparation of cellular proteins of Listeria monocytogenes strains. Overnight cultures of L. monocytogenes were diluted 1:25 into defined minimal medium and grown to an optical density of 0.6 at 600 nm. Each culture was then centrifuged for 5 min at an RCF of 5,500 at 4°C.
For the preparation of cellular proteins (containing ActA), the pellet was washed in phosphate-buffered saline, resuspended in cold lysis buffer (1ϫ phosphate-buffered saline with additional protease inhibitor [Roche]), and transferred into a 2 ml BLUE TUBE (Q-Biogene) filled with silica-sand. The tube was shaken six times for 30 s each at the speed setting 6.5 in a bead beater (FP120 Fast Prep cell disrupter; Thermo Savant). The cell debris was removed by centrifugation at an RCF of 20,000 for 30 min at 4°C.
Total protein concentrations were determined using a protein microassay (Bio-Rad).
SDS-PAGE and immunoblotting. SDS-PAGE was performed according to standard protocols (26) . After SDS-PAGE, cytoplasmatic proteins were blotted onto nitrocellulose membranes, and equivalent loading of the gels was controlled by PonceauS staining of the blotted membranes. Proteins were immunodetected using the following antibodies: rabbit anti-ActA (1:1,000) (38) and goat antirabbit horseradish peroxidase (1:10,000; Dianova).
Animals. Female C57BL/6 mice were purchased from Harlan Winkelmann GmbH, Germany, and were used when they were between 6 and 10 weeks old. All animals were housed under specific-pathogen-free conditions at the Biocenter of the University of Würzburg. All animal experiments were approved by the government of Unterfranken (Lower Franconia) and were performed according to the German animal protection guidelines.
Infection of animals. C57BL/6 recipient mice (groups of five animals) were intravenously infected with 5 ϫ 10 3 bacteria resuspended in 100 l endotoxinfree 0.9% NaCl. Three days postinfection, spleens and livers were collected and homogenized and dilutions (10 Ϫ0 to 10 Ϫ4 ) were plated on brain heart infusion agar to determine the amount of Listeria bacteria in the tested organs. ivanovii, and L. seeligeri (termed PrfA Lm , PrfA Li , and PrfA Ls ), we purified these three PrfA proteins and a constitutively active mutant PrfA protein (PrfA* Lm ) carrying a G145S exchange (42) as recombinant proteins with an N-terminal His 6 tag as previously described (2) . To test whether the positively charged His 6 tag may alter the binding affinity and the transcriptional activation capacity of PrfA, nontagged versions of the wild-type PrfA Lm protein and the mutant PrfA* Lm protein were overexpressed in E. coli by using the pET-3c vector system and also purified (Fig. 1) .
RESULTS

Purification of His
With these PrfA proteins, the kinetic and equilibrium constants of binding to target DNA were determined using a Biacore SA chip. In one flow cell, an immobilized 28-mer oligonucleotide that contained the 14-bp PrfA box of the L. monocytogenes hly promoter (Phly Lm ) flanked by 7 bp of the 5Ј and 3Ј regions of this box was coupled to the SA chip. As a reference, in the other flow cell of the same chip, a 28-bp nonspecific DNA fragment was used. The DNA binding abilities of all purified PrfA proteins (nontagged PrfA Lm , nontagged PrfA* Lm , PrfA Lm , PrfA* Lm , PrfA Li , and PrfA Ls ) were analyzed. The kinetics of the interaction of PrfA with the PrfA box of the hly promoter could be precisely measured for non- Table 2 demonstrate that nontagged PrfA* Lm DNA binding is about 50-fold stronger than that of nontagged PrfA Lm and that PrfA Lm binding to the Phly Lm PrfA box is about eightfold stronger than binding of nontagged PrfA Lm . As the association rate constant (k a ) of nontagged PrfA* Lm DNA binding is marginally higher than the range for kinetic analysis with the Biacore X instrument, we state only an approximate value for this equilibrium constant. The K D values of PrfA Lm and PrfA Li DNA binding are almost equal. The equilibrium constant of PrfA Ls could not be determined exactly, since this protein partially precipitates after dialysis in the applied running buffer. The obtained (still preliminary) data suggest, however, that the equilibrium constant of PrfA Ls is at least 10-fold lower than that of PrfA Lm . The analysis of PrfA* Lm binding to the Phly Lm PrfA box showed that the association rate is far above 10 7 M Ϫ1 s Ϫ1 and therefore not reliably quantifiable with the Biacore X instrument. Nevertheless, these measurements showed that the PrfA* Lm interaction with the Phly Lm PrfA box is clearly stronger than the interaction with the nontagged PrfA* Lm . Therefore, it seems that the presence of an N-terminal His 6 tag increases PrfA binding to the Phly Lm PrfA box.
Determination of the binding affinity of the PrfA proteins with and without RNA polymerase to the PrfA-dependent promoter Phly Lm by EMSA. As previously described (1, 2), the CIII complex consists of PrfA bound to the PrfA box within the promoter sequence, and the ternary CI complex is composed of RNAP, PrfA, and the promoter sequence, while the CII represents a complex with RNAP bound to the promoter sequence in the absence of PrfA. The capacities of all purified PrfA proteins to form CIII and CI complexes were determined by EMSA.
For these studies, the complete hly promoter of L. monocytogenes (Phly Lm ) had to be used as the target sequence, since the CI complex is formed only with the entire promoter, and previous results have shown that CIII complex formation is more efficient with the full promoter sequence than with the PrfA box alone (7). In the presence of constant amounts of Phly Lm promoter fragment (about 5 nM), CIII complex formation was readily observed with the His 6 -tagged PrfA Li and PrfA* Lm (Fig. 3A and C, lanes 3, 5, 7, 9 , and 11). With increasing concentrations of these PrfA proteins, saturation of CIII complex formation was reached at 60 nM for PrfA Li and 18 nM for PrfA* Lm . The efficiency of CIII complex formation was considerably lower for His 6 -tagged PrfA Lm (230 nM) (Fig.  3B) . Under these conditions, no CIII complex was detected with PrfA Ls , even when the PrfA protein concentration was raised up to 3. 
Nontagged PrfA Lm ference in binding affinity between PrfA Lm and PrfA Li is less pronounced in the Biacore X assays than in the EMSAs, and this may be due to the different running buffers that had to be used for these measurements. This assumption is supported by the observation that PrfA Ls precipitated in the Biacore running buffer (see above) but not in the buffer used for the EMSAs. In parallel to the CIII complex formation, the formations of CI and CII complexes were also determined by the addition of a constant amount (1.5 nM) of partially purified L. monocytogenes RNAP to the binding assays (Fig. 3A to D, lanes 4, 6, 8,  10 , and 12). At this RNAP concentration, saturation of CI complex formation (defined as the point where the entire CII complex, indicative of free RNAP bound to the promoter fragment, was completely shifted to CI) with PrfA Li , PrfA Lm , and PrfA* Lm was reached at concentrations of 60 nM, 230 nM, and 6 nM, respectively, i.e., at roughly the same concentrations observed for the saturation of the corresponding CIII complexes (Fig. 3A to C) . Especially with PrfA Lm , we repeatedly observed at concentrations above saturation a decrease in the amount of CI and CIII complexes, which may be due to the formation of higher PrfA aggregates. These PrfA oligomers may no longer bind to the PrfA box and/or to RNAP.
With increasing PrfA Ls concentrations, a band whose migration rate did not differ from that of the CII band (formed with the added RNAP alone) but whose intensity increased with increasing amounts of PrfA Ls (Fig. 3D) was formed, suggesting that PrfA Ls is involved in the formation of this band. We therefore performed supershift assays using purified anti-PrfA antibodies and observed an up-shifted band which was now clearly separated from the CII band (Fig. 3E) . Based on this supershifted CI band, we conclude that saturation of CI formation with PrfA Ls was reached at 3.5 M s-PrfA protein (Fig.  3D) , i.e., at a concentration almost 500-fold higher than that of PrfA* Lm .
Interestingly, the supershifted band obtained with PrfA Ls migrates at a significantly higher rate than the supershifted band obtained with PrfA Lm (both formed under the same conditions) (Fig. 3F) , which suggests that less PrfA Ls molecules may be bound in the PrfA Ls -mediated CI complex than in the corresponding CI complex formed with PrfA Lm .
To determine whether the applied RNAP concentration in the CI complex formation assays described above is indeed at a saturating level, we performed EMSAs by adding increasing concentrations of RNAP to the four PrfA proteins at the concentrations which showed saturation in the CIII formation assays described above. As shown in Fig. 4A and B, at the indicated PrfA concentrations, concentrations of RNAP lower than 1.5 nM (Fig. 3) were quantitatively shifted into CI (no CII complex observed) with PrfA Lm , PrfA* Lm , PrfA Li , and PrfA Ls , while a higher RNAP concentration (3 nM) yielded only slightly more CI complex, indicating that the RNAP concentration for which results are shown in Fig. 3 is near saturation.
There were still large amounts of free CIII complex, especially in cases of PrfA* Lm and PrfA Li (Fig. 4B ) under these conditions, that apparently could not be shifted to CI even in presence of the higher RNAP concentration. The opposite seems to be the case for PrfA Lm and especially PrfA Ls . With PrfA Lm , CI complex is already formed under conditions where CIII complex formation is not yet observed (Fig. 3B ) and no CIII complex is detected at all with PrfA Ls (Fig. 4A) .
These data confirm that PrfA* Lm and PrfA Li bind more strongly to their specific PrfA boxes (forming CIII complexes) than PrfA Lm and PrfA Ls . But more importantly, these data suggest that preformed CIII complexes with PrfA* Lm and PrfA Li (and, to some extent, even with PrfA Lm ) are not easily shifted to CI, even in the presence of high RNAP concentrations. It is therefore likely that the formation of the transcriptionally active ternary CI complex is formed by the simultaneous interaction of all three partners. The binding efficiency of a given PrfA to its binding site alone (CIII formation) would then not necessarily indicate its potential to initiate transcription at a PrfA-dependent promoter. The N-terminal His 6 tag of PrfA enhances CIII complex formation but not the efficiency of CI complex formation and of in vitro transcription initiation. The difference between the His 6 -tagged PrfA Lm and PrfA* Lm and their untagged counterparts was determined in similar binding assays as described in the legend to Fig. 3 by using constant amounts of Phly Lm fragment (Fig. 5A) or PactA Lm fragment (Fig. 5C) , each 5 nM, and RNAP (1.5 nM). The applied PrfA concentration was always chosen close to saturation for the His 6 -tagged versions determined as described in the legend to Fig. 3 .
As depicted in Fig. 5A and C (lower lanes), PrfA* Lm and PrfA Lm showed higher efficiencies of CIII formation than the untagged PrfA* Lm and untagged PrfA Lm proteins (almost 10-fold in the cases of PrfA* Lm and untagged PrfA* Lm at Phly Lm ). At the applied PrfA concentrations, CIII complex formation with the Phly and PactA fragments could not even be observed in the case of untagged PrfA Lm , and CIII formation was weak with PrfA Lm . These data indicate that the His 6 tag enhances binding of PrfA to the PrfA target sequence considerably, in agreement with the Biacore X determinations ( Table 2) . Interestingly, the N-terminal His 6 tag of PrfA did not show a corresponding increase in CI formation. As shown in the upper lanes of Fig. 5A and C, the difference between the His 6 -tagged and corresponding untagged PrfA proteins was at most a factor of two.
We next determined whether the efficiency of CI formation corresponds to the efficiency of initiating transcription at the PrfA-dependent promoters by using the previously described runoff in vitro transcription assay (1, 31) . As shown in Fig. 5B and D, this indeed appears to be the case. At constant concentrations of RNAP and promoter fragments similar to those used in the assays whose results are shown in Fig. 3 , we obtained, with increasing amounts of the His 6 -tagged and untagged versions of PrfA Lm and PrfA* Lm , runoff transcripts which differed in their amounts at most by, again, a factor of two. Moreover, there was not much difference between the abilities of PrfA and PrfA* to initiate in vitro transcription at Phly and PactA.
Binding of PrfA Lm , PrfA* Lm , PrfA Li , and PrfA Ls to the hly and actA promoters of L. monocytogenes, L. ivanovii, and L. seeligeri and their in vitro transcription activation. Since there are significant species-specific differences in the promoter sequences of the hly and actA genes (affecting less the PrfA box and Ϫ10 sequences and more the adjacent sequences) (Fig. 6) , we tested whether the PrfA proteins of the three Listeria species may be more adapted to their specific PrfA-dependent promoters. For this goal, we measured again binding affinity and transcriptional activation of His 6 -tagged PrfA Lm , PrfA* Lm , PrfA Li , and PrfA Ls with the hly and actA promoters of each of the three species (termed Phly Lm , Phly Li , Phly Ls , and PactA Lm , PactA Li , and PactA Ls ). In all cases, the optimal concentrations for the PrfA proteins were chosen as determined in the assays described in the legend to Fig. 3 , while a constant concentration of the promoter fragment (5 nM) was used. As shown in Fig. 7 , similar binding efficiencies (determined by the formation of the CIII complex), determined as described above for binding to Phly Lm , were observed between the different PrfA proteins and the two other species-specific Phly and PactA promoter fragments. A slower-moving CIII complex (designated CIIIa) (Fig. 7) was observed with the high concentration of PrfA Ls (and sometimes with PrfA Li and PrfA* Lm ) and the studied Phly fragment and, particularly, the PactA promoter fragment. Since the used concentration of PrfA Ls was much higher than those of the other PrfA proteins, it is possible that these higher complexes formed with PrfA Ls are more stable than the normal CIII complex, which seems to consist of a PrfA dimer bound to the promoter. It is also noticeable that the CIII complex formed with PrfA Li always migrated (for an unknown reason) slightly slower than those formed with PrfA Lm and PrfA* Lm (Fig. 7) . Binding of PrfA Li and binding of PrfA* Lm to all tested promoters were again the most efficient, and the binding of PrfA Li to these promoters was comparable to that of PrfA* Lm . The CI formation efficiencies observed with PrfA Lm , PrfA* Lm , PrfA Ls , and PrfA Li were quite similar in all analyzed promoter fragments. Note that CI formation with PrfA Ls required amounts of this protein that were at least 20-fold larger than than the amounts of the other PrfA proteins (Fig. 7) . In vitro transcription initiation induced by the different PrfA proteins at these promoters was also examined. In each case, PrfA* Lm showed an activity that was only slightly higher (Ͻ2-fold) than those of PrfA Lm and PrfA Li , whereas more than 20-fold-larger amounts of PrfA Ls were needed for a transcription efficiency similar to that with PrfA Lm (Fig. 8) . These results indicate that there are no species-specific preferences for the different PrfA proteins to the homologous and heterologous actA and hly promoters used in this study.
Replacement of the C-terminal 38 amino acids of PrfA Ls with those of PrfA Lm leads to a significantly higher transcrip- tion activation at Phly Ls and PactA Lm . As shown in Fig. 9A , there is a clustering of amino acid exchanges in the C-terminal region of PrfA Ls (amino acids 200 to 237) compared to that of PrfA Lm or PrfA Li , whereas the other differences in the amino acid sequence between PrfA Ls and PrfA Li or PrfA Lm are rather randomly distributed. The C-terminal region has been shown to be critical for PrfA function (18) . We therefore replaced this region of PrfA Ls with that of PrfA Lm , purified the hybrid protein PrfA Lsm (Fig. 1) , and determined the binding affinity and the transcriptional activation capacity in comparison with those of PrfA Lm and PrfA Ls . As shown in Fig. 9B , both properties of this hybrid, PrfA Lsm , were improved compared to those of PrfA Ls but did not reach those of PrfA Lm , suggesting that some of the other amino acid exchanges in PrfA Ls may be even more decisive for the low activity of PrfA Ls than the amino acid differences in the C-terminal region. (Fig. 10A) , and showed a significantly reduced virulence in the mouse sepsis model (Fig.  10B) , indicating that the PrfA Ls protein contributes to the low virulence of L. seeligeri.
DISCUSSION
PrfA, first identified as the key regulator of virulence genes of L. monocytogenes (29) , was later also found in the animal pathogenic species L. ivanovii and in the nonpathogenic species L. seeligeri (16, 28) but not in the strictly environmental saprophytes Listeria innocua and Listeria welshimeri (8, 17) . Recent phylogenetic studies of the various Listeria species suggest that the prfA gene, which is part of a gene cluster (now termed LIPI-1) (24) , is inserted together with LIPI-1 into the listerial chromosome rather early in evolution but is again deleted together with LIPI-1 in L. innocua and L. welshimeri (4, 45) .
The genes which are transcriptionally activated by PrfA in L. monocytogenes and L. ivanovii encode primarily virulence factors enabling these bacteria to enter nonphagocytic mammalian cells and to survive and replicate efficiently in the host cell's cytosol. The limited data available from previous studies on the expression of L. seeligeri genes that are presumably under PrfA Ls control (23, 51) show low expression of these genes when L. seeligeri is grown in culture media or in mammalian cells (22) . This reduced gene expression could be caused by altered regulation of the prfA Ls gene expression, by an altered mechanism of activation of PrfA Ls compared to PrfA Lm and PrfA Li , or by the altered amino acid composition of PrfA Ls .
Since in vivo PrfA activity is regulated by complex, not yet fully understood additional factors and metabolic conditions (7, 10, 34, 35, 41, 43) which may be different in the three listerial species (23), we have chosen in the present study to purify the three PrfA proteins and to compare their binding affinities to homologous (deriving from the same species) and heterologous (deriving from other listerial species) PrfA-dependent promoters. Additionally, we determined their capacities to initiate transcription at these promoters in vitro.
Purified PrfA Lm has been previously shown to be active in vitro, exhibiting a transcriptional initiation capacity at PrfAcontrolled promoters which is quite similar to that of the purified constitutively active PrfA* Lm (31, 53) . Different from the situation in vitro, wild-type PrfA activity in vivo is positively or negatively modulated under certain physiological conditions (15, 23) , while PrfA* remains constitutively active independent of the culture conditions (43) . This difference between in vitro and in vivo activity suggests that wild-type PrfA activity in vivo is modulated by a still unknown cellular factor(s).
Binding affinities of the various PrfA proteins to their specific binding sites (the PrfA boxes) was determined by two methods: (i) by measuring the equilibrium constants of PrfA to an oligonucleotide that contains the binding site of Phly Lm only and (ii) by measuring the binding affinity of PrfA to the entire PrfA box-containing promoter by EMSA. The latter was done, as previous experiments had shown that binding affinity of PrfA is highly inefficient when one uses the PrfA box oligonucleotide only and complex formation (CIII) could be observed only with a high PrfA concentration (7) .
The data obtained by the two different assays show similar trends with respect to the binding of the PrfA proteins and confirm the earlier notion that purified PrfA without any additional factor is already in an (at least partially) active conformation. The nanomolar equilibrium constants suggest that already one to five molecules of purified PrfA Lm protein, as well as nontagged PrfA Lm , per cell could bind efficiently to the PrfA boxes, which seems to be the initial step of PrfA-mediated transcription activation. It should be noticed that the equilibrium constants of PrfA Lm and PrfA* Lm determined in this study are considerably lower than those determined by Eiting and coworkers (9) ; this may be due to the different PrfA preparations. Both experiments showed binding affinities of PrfA* that were higher than those of PrfA, which, in our measurements, were 18-fold higher in the case of His 6 -tagged PrfA proteins (9) and 50-fold higher with untagged PrfA proteins.
Although the Biacore X and EMSA experiments lead to the conclusion that the His 6 -tagged PrfA proteins bind significantly better to their target sites than their untagged counter-parts, the in vitro transcription studies show that the transcriptional activation capacity of wild-type PrfA is not due to the applied N-terminal His 6 tag. Both untagged PrfA Lm proteins show only a slightly reduced activation to initiate transcription at the PrfA-dependent promoters Phly and PactA compared to the His 6 -tagged PrfA proteins despite the much greater difference (up to 10-fold) between the abilities of the His 6 -tagged and the untagged PrfA proteins to bind to the target sites (PrfA boxes). These data suggest that PrfA binding to the PrfA box alone does not necessarily reflect the efficiency of transcription initiation at PrfA-dependent promoters.
This conclusion is also supported by the comparative binding and transcriptional activation exerted by the other PrfA proteins analyzed. The purified (His 6 -tagged) PrfA proteins of L. monocytogenes, L. ivanovii, and L. seeligeri show remarkable differences in binding affinity to PrfA-dependent homologous and heterologous listerial promoters when measured by EMSA. The PrfA Li shows (in the absence of RNA polymerase) a binding affinity to the hly and actA promoters of L. monocytogenes, L. ivanovii, and L. seeligeri, which is similar to that of PrfA* Lm and more than 2 logs higher than that of wild-type PrfA Lm . It has not been experimentally clarified what causes the high binding affinity of PrfA Li compared to that of PrfA Lm . Among the various amino acid exchanges which were previously shown to lead to PrfA* Lm activity (42, 47, 49, (52) (53) (54) (these mutations are also indicated in Fig. 9A ), an amino acid exchange at position 183 is also present in PrfA Li (S183C) compared to the amino acid sequence of PrfA Lm (S183A) (47) and may contribute to the enhanced binding of PrfA Li compared to PrfA Lm .
Contrary to the different binding efficiencies of PrfA* Lm and PrfA Li on one hand and PrfA Lm on the other to the various PrfA box-containing promoters in the absence of RNAP, the efficiencies of all three PrfA proteins to form the ternary transcription complex between PrfA, RNAP, and the PrfA promoter sequence (CI complex) are rather similar. The CI complex formation capacity also parallels the abilities of these PrfA proteins to initiate in vitro transcription at the PrfA-dependent promoters; these abilities are almost equal for PrfA Li and PrfA Lm , and that of PrfA* Lm is at most twofold higher. These data are thus in accord with the conclusion given above, that the efficiency of the binding of PrfA to its specific site alone does not determine its ability to form a transcriptionally active initiation complex. The data rather suggest that the simultaneous interaction of PrfA with RNAP and the PrfA box-containing promoter sequence may be decisive for the formation of a transcriptionally active complex, and this property seems to be quite similarly expressed among all three PrfA proteins.
The correlation of the efficiency of PrfA binding to its target site and transcription activation at PrfA-dependent promoters is most evident in case of PrfA Ls . This PrfA protein has a drastically lower binding affinity to all studied PrfA boxes than the other PrfA proteins and, in parallel, an equally reduced ability to form the ternary CI complex with RNAP and to initiate transcription at all studied PrfA-dependent promoters. Furthermore, the supershift experiments performed with the PrfA Ls -and PrfA Lm -mediated CI complexes (using purified polyclonal anti-PrfA antibodies) suggest that less PrfA Ls molecules may be bound to the PrfA Ls -mediated CI complex than are bound to that formed with PrfA Lm , which may be due to a limited capacity of PrfA Ls to form functional dimers. These monocytogenes EGD-e prfA Lm . The strains were grown to an optical density at 600 nm of 0.6 in minimal medium supplemented with 50 mM cellobiose or glycerol. Cytoplasmic proteins were prepared, and equal amounts (5 g) were separated by SDS-PAGE and analyzed by Western blotting. After use of a loading control with PonceauS, immunodetection of ActA protein (␣-ActA) was performed. Protein preparations of the strain L. monocytogenes EGD-e ⌬actA (S. Pilgrim and S. Bauer, unpublished data) are also shown as a negative control. The hemolytic activities of L. monocytogenes EGD-e prfA Ls and L. monocytogenes EGD-e prfA Lm grown in minimal medium to an optical density at 600 nm of 0.6 are shown to the right. The hemolytic activity was determined in three independently performed experiments; the error bars indicate standard deviations of the means for the three experiments. (B) Viable bacterial counts in spleens and livers of C57BL/6 mice infected intravenously with 5 ϫ 10 3 CFU of wild-type L. monocytogenes EGD-e or L. monocytogenes EGD-e prfA Ls (EGD-e s-prfA). Bacterial loads in spleens and livers of infected animals are shown. Each symbol represents a single animal. The lines indicate the means for the experimental groups (n ϭ 5). For each organ, the P value determined with Student's t test of the log-transformed CFU amounts is given. L. monocytogenes EGD-e prfA Ls was highly significantly (P Յ 0.01) attenuated compared to the wild-type strain. 
